Skip to Content

Walvax Biotechnology Co Ltd Class A 300142

Morningstar Rating
CNY 14.25 −0.04 (0.28%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

300142 is trading at a 28% discount.
Price
CNY 14.35
Fair Value
CNY 11.89
Uncertainty
High
1-Star Price
CNY 53.84
5-Star Price
CNY 85.54
Economic Moat
Xckcs
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 300142 is a good fit for your portfolio.

Trading Information

Previous Close Price
CNY 14.29
Day Range
CNY 14.0614.39
52-Week Range
CNY 13.6533.40
Bid/Ask
CNY 14.24 / CNY 14.25
Market Cap
CNY 22.90 Bil
Volume/Avg
14.4 Mil / 18.9 Mil

Key Statistics

Price/Earnings (Normalized)
39.58
Price/Sales
5.53
Dividend Yield (Trailing)
0.07%
Dividend Yield (Forward)
0.07%
Total Yield
0.07%

Company Profile

Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Growth
Total Number of Employees
2,388

Comparables

Valuation

Metric
300142
300841
300601
Price/Earnings (Normalized)
39.5814.3629.67
Price/Book Value
2.442.222.34
Price/Sales
5.534.928.66
Price/Cash Flow
17.1312.6129.08
Price/Earnings
300142
300841
300601

Financial Strength

Metric
300142
300841
300601
Quick Ratio
1.47
Current Ratio
2.15
Interest Coverage
2.18
Quick Ratio
300142
300841
300601

Profitability

Metric
300142
300841
300601
Return on Assets (Normalized)
1.93%
Return on Equity (Normalized)
2.94%
Return on Invested Capital (Normalized)
2.09%
Return on Assets
300142
300841
300601
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AFnjkcpqxvhWwvck$70.0 Bil
MKKGY
Merck KGaA ADRSxcbcnqjrXqxhpm$68.4 Bil
HLN
Haleon PLC ADRCvdmbjmBpyd$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRXswhshzsxTdzqg$14.5 Bil
VTRS
Viatris IncKvqhgmplFpmk$13.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRBlfxrdjbZtdf$12.0 Bil
CTLT
Catalent IncYdllqywrKhdxdw$10.1 Bil
PRGO
Perrigo Co PLCTmvdchrmGtsp$4.1 Bil
CURLF
Curaleaf Holdings IncNzgtzvrMdgwn$3.6 Bil
PBH
Prestige Consumer Healthcare IncXdxjfmlFmxfj$3.5 Bil

Sponsor Center